INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $459,792 | -81.9% | 24,800 | -89.2% | 0.00% | -75.0% |
| Q2 2023 | $2,540,482 | -21.9% | 229,700 | -5.2% | 0.01% | -33.3% |
| Q1 2023 | $3,252,746 | +3.2% | 242,200 | -5.0% | 0.01% | +71.4% |
| Q4 2022 | $3,153,113 | -14.1% | 254,900 | -3.1% | 0.01% | 0.0% |
| Q3 2022 | $3,669,000 | +193.3% | 263,000 | +190.3% | 0.01% | +250.0% |
| Q2 2022 | $1,251,000 | -43.6% | 90,600 | -33.5% | 0.00% | 0.0% |
| Q1 2022 | $2,218,000 | -25.4% | 136,300 | -25.3% | 0.00% | 0.0% |
| Q4 2021 | $2,973,000 | +103.6% | 182,500 | +85.7% | 0.00% | 0.0% |
| Q3 2021 | $1,460,000 | +33.5% | 98,300 | +79.4% | 0.00% | +100.0% |
| Q2 2021 | $1,094,000 | -60.9% | 54,800 | -54.8% | 0.00% | -75.0% |
| Q1 2021 | $2,797,000 | -31.9% | 121,200 | -27.1% | 0.00% | -42.9% |
| Q4 2020 | $4,105,000 | +16.9% | 166,200 | +96.2% | 0.01% | -36.4% |
| Q3 2020 | $3,512,000 | -31.7% | 84,700 | -21.1% | 0.01% | -54.2% |
| Q2 2020 | $5,141,000 | -33.3% | 107,300 | -12.4% | 0.02% | -61.9% |
| Q1 2020 | $7,713,000 | -81.0% | 122,500 | -62.6% | 0.06% | -77.2% |
| Q4 2019 | $40,559,000 | +143.5% | 327,300 | +30.4% | 0.28% | +104.4% |
| Q3 2019 | $16,656,000 | +56.9% | 251,000 | +88.2% | 0.14% | +40.6% |
| Q2 2019 | $10,615,000 | -67.3% | 133,400 | -54.0% | 0.10% | -73.5% |
| Q1 2019 | $32,462,000 | +98.1% | 290,200 | +78.5% | 0.36% | +154.9% |
| Q4 2018 | $16,388,000 | +17.0% | 162,600 | +46.8% | 0.14% | +27.9% |
| Q3 2018 | $14,001,000 | +182.8% | 110,800 | +87.8% | 0.11% | +164.3% |
| Q2 2018 | $4,951,000 | +78.4% | 59,000 | +30.8% | 0.04% | +50.0% |
| Q1 2018 | $2,775,000 | -21.7% | 45,100 | -25.7% | 0.03% | +12.0% |
| Q4 2017 | $3,546,000 | -33.4% | 60,700 | -33.9% | 0.02% | -47.9% |
| Q3 2017 | $5,328,000 | +122.3% | 91,800 | +363.6% | 0.05% | +92.0% |
| Q2 2017 | $2,397,000 | -36.2% | 19,800 | -40.4% | 0.02% | -43.2% |
| Q1 2017 | $3,755,000 | -36.5% | 33,200 | -39.0% | 0.04% | -22.8% |
| Q4 2016 | $5,911,000 | +44.2% | 54,400 | +118.5% | 0.06% | +29.5% |
| Q3 2016 | $4,098,000 | +34.8% | 24,900 | +16.9% | 0.04% | +22.2% |
| Q2 2016 | $3,039,000 | +40.0% | 21,300 | +26.0% | 0.04% | +16.1% |
| Q1 2016 | $2,171,000 | +209.3% | 16,900 | +259.6% | 0.03% | +287.5% |
| Q4 2015 | $702,000 | +28.3% | 4,700 | +42.4% | 0.01% | 0.0% |
| Q3 2015 | $547,000 | -65.7% | 3,300 | -50.0% | 0.01% | -63.6% |
| Q2 2015 | $1,593,000 | -62.6% | 6,600 | -56.3% | 0.02% | -67.2% |
| Q1 2015 | $4,259,000 | +1415.7% | 15,100 | +738.9% | 0.07% | +1575.0% |
| Q4 2014 | $281,000 | -8.8% | 1,800 | +38.5% | 0.00% | -20.0% |
| Q3 2014 | $308,000 | +8.5% | 1,300 | +8.3% | 0.01% | +25.0% |
| Q2 2014 | $284,000 | -90.3% | 1,200 | -86.5% | 0.00% | -91.8% |
| Q1 2014 | $2,935,000 | – | 8,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,200,000 | $22,248,000 | 10.22% |
| GROUP ONE TRADING, L.P. | 24,800 | $459,792 | 0.00% |
| SIMPLEX TRADING, LLC | 53,200 | $986 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 68,500 | $1,269,990 | 0.00% |